Literature DB >> 10619672

Dopamine D3 agonists into the substantia nigra aggravate cataplexy but do not modify sleep.

K Honda1, J Riehl, E Mignot, S Nishino.   

Abstract

We have recently demonstrated that local perfusion of dopaminergic D2/D3 agonists into the ventral tegmental area (VTA) significantly aggravates cataplexy and increases sleep in narcoleptic Dobermans. We further assessed the roles of the mesostriatal dopaminergic system and found that local perfusion of quinpirole and 7-OH-DPAT into the substantia nigra (SN) significantly aggravated cataplexy, while perfusion of a D2/D3 antagonist significantly reduced cataplexy. Neither a D1 agonist nor a D1 antagonist modified cataplexy. SN perfusion of quinpirole did not significantly modify sleep, while VTA perfusion significantly increased the drowsy state. Although autoregulation of the VTA and SN dopaminergic neurons are involved in the regulation of cataplexy, both structures have distinct roles for the regulation of sleep.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619672     DOI: 10.1097/00001756-199911260-00046

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  7 in total

1.  Dopaminergic regulation of sleep and cataplexy in a murine model of narcolepsy.

Authors:  Christian R Burgess; Gavin Tse; Lauren Gillis; John H Peever
Journal:  Sleep       Date:  2010-10       Impact factor: 5.849

2.  Serotonin neurons in the dorsal raphe mediate the anticataplectic action of orexin neurons by reducing amygdala activity.

Authors:  Emi Hasegawa; Takashi Maejima; Takayuki Yoshida; Olivia A Masseck; Stefan Herlitze; Mitsuhiro Yoshioka; Takeshi Sakurai; Michihiro Mieda
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-10       Impact factor: 11.205

Review 3.  Clinical and neurobiological aspects of narcolepsy.

Authors:  Seiji Nishino
Journal:  Sleep Med       Date:  2007-04-30       Impact factor: 3.492

4.  Animal models of narcolepsy.

Authors:  Lichao Chen; Ritchie E Brown; James T McKenna; Robert W McCarley
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-08       Impact factor: 4.388

5.  Screening for candidate gene regions in narcolepsy using a microsatellite based approach and pooled DNA.

Authors:  Stefan Wieczorek; Peter Jagiello; Larissa Arning; Norbert Dahmen; Joerg T Epplen
Journal:  J Mol Med (Berl)       Date:  2004-08-07       Impact factor: 4.599

6.  Polysomnographic Sleep Disturbances Due to High-Dose Zolpidem Use: A Case Report.

Authors:  Hayato Ohshima; Nozomu Kotorii; Minoru Takii; Hiroshi Hiejima; Mitsunari Habukawa; Hiroo Kuwahara; Naohisa Uchimura
Journal:  J Clin Sleep Med       Date:  2018-11-15       Impact factor: 4.062

7.  Complex movement disorders at disease onset in childhood narcolepsy with cataplexy.

Authors:  Giuseppe Plazzi; Fabio Pizza; Vincenzo Palaia; Christian Franceschini; Francesca Poli; Keivan K Moghadam; Pietro Cortelli; Lino Nobili; Oliviero Bruni; Yves Dauvilliers; Ling Lin; Mark J Edwards; Emmanuel Mignot; Kailash P Bhatia
Journal:  Brain       Date:  2011-09-19       Impact factor: 13.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.